The Lifestyle Education About Prediabetes (Leap) Study
LEAP
Testing a Very Low-carbohydrate Diet Version of the Diabetes Prevention Program to Reduce Risk Factors for Type 2 Diabetes: The LEAP (Lifestyle Education About Prediabetes) Study
2 other identifiers
interventional
304
1 country
1
Brief Summary
This research will test whether a standard version or very low-carbohydrate version of the Diabetes Prevention Program better improves outcomes like blood glucose control and body weight for patients with prediabetes. Participants will have screening (includes blood draw) and baseline testing with a continuous glucose monitor. Once these enrollment steps are completed and the participants will be randomized to one of two groups: standard National Diabetes Prevention Program (NDPP) or a very low-carbohydrate version. In addition to the diet (12 months) participants will be asked to participate in hour-long weekly group classes over zoom. After four months in the program, classes will occur about every month to help participants maintain the new diet. There will also be check-ins and follow-up visits through out the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 2, 2022
CompletedFirst Posted
Study publicly available on registry
February 11, 2022
CompletedStudy Start
First participant enrolled
March 20, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 14, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 14, 2025
CompletedDecember 19, 2025
December 1, 2025
3.7 years
February 2, 2022
December 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in HbA1c
HbA1c levels will be measured by standard immunoturbidimetric assay methods and quality control measures at a Clinical Laboratory Improvement Amendments (CLIA) certified lab.
0 to 12 months
Secondary Outcomes (7)
Change in Inflammation based on C-reactive protein (CRP)
0 to 12 months
Change in percent body weight loss
0-12 months
Change in glycemic variability
0 to 12 months
Change in small particle low-density lipoproteins (LDL)
0 to 12 months
Change in high-density lipoproteins (HDL)
0 to 12 months
- +2 more secondary outcomes
Study Arms (2)
Standard NDPP
ACTIVE COMPARATOR12-month long, calorie-restricted NDPP
Very low-carbohydrate diet (VLCD)
EXPERIMENTALVLCD is an adaptation of the standard NDPP curriculum, which preserves all features with the exception of altered dietary advice.
Interventions
Participants in this arm will be taught to manage their prediabetes with the Centers for Disease Control's standard National Diabetes Prevention Program. It teaches a lower calorie, lower fat diet. There will be a core phase and a maintenance phase of this study; the core phase will last for about 4 months and will involve weekly or every other week classes, home assignments, and brief check-in surveys. The maintenance phase will last for the remaining time, with classes and check-in surveys approximately once a month.
Participants in this arm will be taught to manage their prediabetes with the Centers for Disease Control's National Diabetes Prevention Program, adapted to teach a very low-carbohydrate diet, also called a ketogenic or "keto" diet. This diet involves eating non-starchy vegetables, leafy greens, cheese, meats, berries, nuts, and seeds and avoiding starchy foods like pasta, bread, rice, beans, many fruits, etc. There will be a core phase and a maintenance phase of this study; the core phase will last for about 4 months and will involve weekly or every other week classes, home assignments, and brief check-in surveys. The maintenance phase will last for the remaining time, with classes and check-in surveys approximately once a month.
Eligibility Criteria
You may qualify if:
- overweight, defined as BMI \>= 25 kg/m2 \>= 23 kg/m2 if of Asian descent
- HbA1c between 5.7% - 6.4% verified at baseline
- willingness to participate in group-based sessions
- able to engage in at least light physical activities such as walking
- willingness to follow a prescribed diet, be randomized, self-weight, track diet, and report physical activity minutes
- physician approval to participate
You may not qualify if:
- history of type 1 diabetes or type 2 diabetes
- use of anti-obesity medications or participation in another weight loss program or intervention
- use of glucose lowering medications other than metformin
- pregnant or planning to become pregnant during the intervention period
- breastfeeding
- use of oral corticosteroids
- previous bariatric surgery or planning to have bariatric surgery during the study period
- blood disorders that influence HbA1c, including frequent blood transfusions, phlebotomy, anemia, hemoglobinopathy, polycythemia
- any condition for which the study team deems participation to be unsafe or inappropriate
- inability to read, write, or speak English
- inability to provide informed consent
- adherence to a vegan or vegetarian diet
- adherence to a very low-carbohydrate (keto) diet
- difficulty chewing or swallowing
- no influence over what foods are purchased, prepared, and/or served
- +9 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48109, United States
Related Publications (1)
Griauzde DH, O'Brien A, Yancy WS Jr, Richardson CR, Krinock J, DeJonckheere M, Isaman DJM, Vanias K, Shopinski S, Saslow LR. Testing a very low-carbohydrate adaption of the Diabetes Prevention Program among adults with prediabetes: study protocol for the Lifestyle Education about prediabetes (LEAP) trial. Trials. 2022 Sep 30;23(1):827. doi: 10.1186/s13063-022-06770-3.
PMID: 36176003DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Laura Saslow, PhD
University of Michigan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcome assessment and data analysis will be masked
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
February 2, 2022
First Posted
February 11, 2022
Study Start
March 20, 2022
Primary Completion
November 14, 2025
Study Completion
November 14, 2025
Last Updated
December 19, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share